The Gap between Estimated Incidence of End-Stage Renal Disease and Use of Therapy

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Anand, Shuchi ^a   Bitton, Asaf ^b   Gaziano, Thomas ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CENTRAL AMERICA; DEATH; DEVELOPING COUNTRY; DIABETES MELLITUS; HEALTH CARE ACCESS; HEMODIALYSIS; HUMAN; HYPERTENSION; INCOME; KIDNEY FAILURE; MORBIDITY; PREVALENCE; RENAL REPLACEMENT THERAPY; RISK FACTOR; SURVIVAL;

DIABETES MELLITUS; GEOGRAPHY; GLOMERULONEPHRITIS; HUMANS; HYPERTENSION; INCIDENCE; INCOME; KIDNEY FAILURE, CHRONIC; RENAL REPLACEMENT THERAPY; SURVIVAL ANALYSIS; UNITED NATIONS;

EID: 84883427310     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072860     Document Type: Article

References (37)

1. White SL, Chadban SJ, Jan S, Chapman JR, Cass A, (2008) How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ 86: 229-237.
2. Wild S, Roglic G, Green A, Sicree R, King H, (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053.
3. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, et al. (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365: 217-223.
4. Barsoum RS, (2006) Chronic kidney disease in the developing world. N Engl J Med 354: 997-999.
5. Jha V, (2004) End-stage renal care in developing countries: the India experience. Ren Fail 26: 201-208.
6. Barsoum RS, (2002) Overview: end-stage renal disease in the developing world. Artif Organs 26: 737-746.
7. Lysaght MJ, (2002) Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 13Suppl 1: S37-40.
8. Grassmann A, Gioberge S, Moeller S, Brown G, (2005) ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 20: 2587-2593.
9. Moosa MR, Kidd M, (2006) The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int 70: 1107-1114.
10. The World Bank (2011) How we Classify Countries The World Bank.
11. National Renal Registry and Malaysian Society of Nephrology (2006) 14th Report of the Malaysian Dialysis and Transplant Registry. National Renal Registry, Malaysian Society of Nephrology.
12. National Disease Registry Office and Health Promotion Board (2000) Third report of the Singapore Renal Registry 1999/2000. National Disease Registry Office, Health Promotion Board.
13. Egyptian Society of Nephrology and Transplantation (2004) Annual report: 2004.
14. Saudi Arabia Center for Organ Transplantation (2008) Annual data report.
15. The Kidney Foundation (2006) Dialysis registry of Pakistan 2005-2006.
16. Australia and New Zealand Dialysis and Transplant Registry (2006) 29th Annual Report. Austalia and New Zealand Dialysis and Transplant Registry.
17. United States Renal Data System (2008) Annual Data Report 2005. United States Renal Data System.
18. European Renal Association-European Dialysis and Transplant Association (2005) Annual Report 2005. European Renal Association-European Dialysis and Transplant Association.
19. Canadian Organ Replacement Register (2007) Treatment of End-Stage Organ Failure in Canada 1996 to 2005. Canadian Organ Replacement Register.
20. Cusumano A, Garcia-Garcia G, Di Gioia C, Hermida O, Lavorato C, et al. (2006) End-stage renal disease and its treatment in Latin America in the twenty-first century. Ren Fail 28: 631-637.
21. Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, et al. (2011) National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 377: 568-577.
22. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, et al. (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378: 31-40. Supplementary Webappendix: 31-358.
23. Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, et al. (1997) Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA 278: 2069-2074.
24. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, et al. (1996) Blood pressure and end-stage renal disease in men. N Engl J Med 334: 13-18.
25. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, et al. (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63: 225-232.
26. Najafi I, (2009) Peritoneal dialysis in iran and the middle East. Perit Dial Int 29Suppl 2: S217-221.
27. Sitprija V (2003) Nephrology in South East Asia: fact and concept. Kidney Int Suppl: S128-130.
28. Abu-Aisha H, Elamin S, (2010) Peritoneal dialysis in Africa. Perit Dial Int 30: 23-28.
29. El Matri Aea, (2008) Renal replacement therapy resources in Africa. Arab Journal of Nephrology and Transplantation 1: 9-14.
30. Goyal M, Mehta RL, Schneiderman LJ, Sehgal AR, (2002) Economic and health consequences of selling a kidney in India. JAMA 288: 1589-1593.
31. Riella MC, Locatelli AJ, (2007) History of peritoneal dialysis in Latin America. Perit Dial Int 27: 322-327.
32. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, et al. (2002) Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13: 1307-1320.
33. Finkelstein FO, Abu-Aisha H, Najafi I, Lo WK, Abraham G, et al. (2009) Peritoneal dialysis in the developing world: recommendations from a symposium at the ispd meeting 2008. Perit Dial Int 29: 618-622.
34. Sesso R, da Silva CB, Kowalski SC, Manfredi SR, Canziani ME, et al. (2007) Dialysis care, cardiovascular disease, and costs in end-stage renal disease in Brazil. Int J Technol Assess Health Care 23: 126-130.
35. Mahmoud KM, Sheashaa HA, Gheith OA, Wafa EW, Agroudy AE, et al. (2010) Continuous ambulatory peritoneal dialysis in Egypt: progression despite handicaps. Perit Dial Int 30: 269-273.
36. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, et al. (1997) End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 277: 1293-1298.
37. Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, et al. (2006) International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 17: 2275-2284.